Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Esaxerenone produces favourable night-time BP-lowering effect in Asians
The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.
Esaxerenone produces favourable night-time BP-lowering effect in Asians
24 Jan 2022
Peak exercise SBP below predicted value tied to future CVD, mortality
A peak systolic blood pressure (SBP) at clinical exercise testing that is slightly lower than the predicted value appears predictive of future cardiovascular disease (CVD) and mortality, suggests a study. Higher peak SBP, however, is not associated with such risks.
Peak exercise SBP below predicted value tied to future CVD, mortality
24 Jan 2022
Upper extremity DVT common in COVID-19 despite proper prophylaxis
About 10 percent of patients with the coronavirus disease 2019 (COVID-19) will suffer from upper extremity deep vein thrombosis despite adequate prophylaxis, a recent study has found.
